Clayton, Dubilier & Rice and TPG late last week submitted a $21 per share offer for animal health company Covetrus, equating to an equity value of approximately $2.9 billion.
Driving the news: The joint offer follows a broadly run Goldman Sachs sale process encompassing strategics and sponsors, sources tell Axios.
